New reimbursement agreements in ex-U.S. markets and label expansions to younger age groups are driving sales of Vertex’s (VRTX) triple therapy cystic fibrosis drug, Trikafta/Kaftrio higher.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
New reimbursement agreements in ex-U.S. markets and label expansions to younger age groups are driving sales of Vertex’s (VRTX) triple therapy cystic fibrosis drug, Trikafta/Kaftrio higher.